Blockchain Revolutionizes Biotechnology: Secure Data in KIWI-biolab
The field of biotechnology is undergoing a significant transformation thanks to the integration of blockchain technology, as reported by Blockchain-Hero. At the forefront of this revolution are biotechnologists Peter Neubauer and Nicolas Cruz Bournazou from the Technical University Berlin. With backing from Germany's Federal Ministry for Education and Research, they have established the KIWI-biolab—a future-oriented laboratory dedicated to developing AI-driven bioprocesses.
Starting in 2025, these pioneers will lead the DATIpilot-Innovationscommunity project BioBlock, which has secured five million euros in funding. The project's primary goal is to create a secure knowledge exchange platform leveraging fragmented data and blockchain technologies. This initiative aims not only to foster innovation but also ensure that shared information adheres to FAIR principles—making it findable, accessible, interoperable, and reusable. Among their partners are industry giants such as Siemens AG and Sartorius Stedim Biotech GmbH.
Advanced Blockchain Stock Faces Decline Despite Positive Yearly Performance
A recent report on AktienCheck highlights an intriguing development regarding Advanced Blockchain stock prices. Despite experiencing a positive yearly performance with a notable 19% increase over the past month alone, current market values remain below expectations.
This discrepancy has sparked concerns among investors about potential future volatility within cryptocurrency markets coupled with uncertainties surrounding regulatory frameworks. Nevertheless, experts maintain optimism largely because innovative projects continue emerging across various sectors within its portfolio, offering long-term growth prospects worth considering despite short-term fluctuations observed recently according to sources closely monitoring developments.
Sources:
